Researchers from the University of Liverpool, Japan, and Argentina have captured atomic-resolution images of an important ...
Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated on a GLP-1 receptor agonist candidate for diabetes and obesity treatment.